CAPN1 promotes the progression of MLL-rearranged acute myeloid leukemia by suppressing SHP-1 and activating MAPK/ERK signaling pathway.
- DOI
- 10.1016/j.bbadis.2026.168459
- Published
- 2026 Sep 10
- Container
- Biochimica et biophysica acta. Molecular basis of disease
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbadis.2026.168459,
title = {CAPN1 promotes the progression of MLL-rearranged acute myeloid leukemia by suppressing SHP-1 and activating MAPK/ERK signaling pathway.},
author = {Liu JY and Cao X and Lu YL and Hu MM and Dou YT and Luo SL and Ji K and Pei QY and Zeng KX and Zheng YG and Cao J and Wu QY and Li F},
year = {2026},
journal = {Biochimica et biophysica acta. Molecular basis of disease},
doi = {10.1016/j.bbadis.2026.168459},
url = {https://doi.org/10.1016/j.bbadis.2026.168459}
}RIS
TY - JOUR TI - CAPN1 promotes the progression of MLL-rearranged acute myeloid leukemia by suppressing SHP-1 and activating MAPK/ERK signaling pathway. AU - Liu JY AU - Cao X AU - Lu YL AU - Hu MM AU - Dou YT AU - Luo SL AU - Ji K AU - Pei QY AU - Zeng KX AU - Zheng YG AU - Cao J AU - Wu QY AU - Li F PY - 2026 JO - Biochimica et biophysica acta. Molecular basis of disease DO - 10.1016/j.bbadis.2026.168459 UR - https://doi.org/10.1016/j.bbadis.2026.168459 ER -
APA
JY, L., X, C., YL, L., MM, H., YT, D., SL, L., K, J., QY, P., KX, Z., YG, Z., J, C., QY, W., & F, L. (2026). CAPN1 promotes the progression of MLL-rearranged acute myeloid leukemia by suppressing SHP-1 and activating MAPK/ERK signaling pathway.. Biochimica et biophysica acta. Molecular basis of disease. https://doi.org/10.1016/j.bbadis.2026.168459
Source records
- pubmed · retrieved 2026-09-25T18:13:37.259Z